Author

James Omel

OpenAlex ID: A5135438245

PA-497 Timing and Resolution of Talquetamab-Related Dysgeusia in Relapsed/Refractory Multiple Myeloma (RRMM): Longitudinal Waterless Empirical Taste Test and Patient Reported Outcomes Profiles From TALisman

2026 · Ajai Chari, Niels WCJ van de Donk, et al. · Clinical Lymphoma Myeloma & Leukemia

MM-793: Early Resolution of Talquetamab Oral Side Effects in Relapsed/Refractory Multiple Myeloma: Updated Waterless Empirical Taste Test and Patient-Reported Outcomes Data From TALisman

2026 · Niels WCJ van de Donk, Rakesh Popat, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MM-793: Early Resolution of Talquetamab Oral Side Effects in Relapsed/Refractory Multiple Myeloma: Updated Waterless Empirical Taste Test and Patient-Reported Outcomes Data From TALisman

2026 · Niels Wcj van de Donk, Rakesh Popat, et al. · Clinical Lymphoma Myeloma & Leukemia

Solitary plasmacytoma of bone (SPB): Randomized phase III trial to evaluate treatment with adjuvant systemic treatment and zoledronic acid (ZA) versus zoledronic acid after definitive radiation treatment (Alliance A061402)

2026 · Douglas Sborov, Anuj Mahindra, et al. · Research Square

Works count: 4

Citation count:

H-index:

I10-index: